October 13, 2009

Prime Therapeutics Receives 2010 TIPPS Certification for Adherence to High Transparency Standards
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, has met high standards of pharmacy cost transparency, earning it 2010 Transparency in Pharmaceutical Purchasing Standards℠ (TIPPS) certification from the HR Policy Association.

September 23, 2009

Prime Therapeutics Hires Jacqueline Chase as Senior Vice President of Human Resources
Prime Therapeutics (Prime), a nationwide pharmacy benefit management (PBM) company, announced today that Jacqueline Chase has joined the organization as senior vice president of human resources

September 2, 2009

Prime Therapeutics' Presents on Specialty Pharmacy at BlueCross BlueShield Association's National Finance, Actuarial and Underwriting Conference
Pharmacy benefit manager Prime Therapeutics (Prime) announced today its participation in the BlueCross BlueShield Association’s 2009 National Finance, Actuarial and Underwriting (NFAU) Conference in Boston, Massachusetts on Friday, September 11.

August 11, 2009

Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record
Though total health care spending in the U.S. is growing at about 6.9 percent - nearly twice the rate of inflation - pharmacy spending has increased at the lowest rate on record for health plans served by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management.

June 17, 2009

New Study Finds 1 in 4 Multiple Sclerosis Patients with High Out-of-Pocket Costs Not Filling Prescriptions
One in four multiple sclerosis (MS) patients are declining to fill their prescriptions likely due to high out-of-pocket costs, according to new research conducted by pharmacy benefits manager Prime Therapeutics (Prime).

April 23, 2009

Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
The Prime Therapeutics LLC (Prime) Board of Directors announced today that Timothy Dickman, President and Chief Executive Officer, has left the company to pursue other interests, effective April 23, 2009.

April 23, 2009

Prime Sponsors at 2009 American Heart Walk
Pharmacy benefit manager Prime Therapeutics (Prime) announced today its participation in the American Heart Association’s Twin Cities Start! Heart Walk.

April 14, 2009

Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population
Research conducted by Prime Therapeutics (Prime) revealed a significant reduction in inappropriate prescription medication use among older adults when a retrospective drug utilization review (RetroDUR) program paired with a provider intervention initiative was implemented.

March 26, 2009

Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy
Pharmacy benefit manager Prime Therapeutics (Prime) announced that three of its clinical pharmacists, Patrick Gleason, PharmD, FCCP, BCPS, Cathy Starner, PharmD and Jeremy Schafer, PharmD were awarded the Journal of Managed Care Pharmacy (JMCP) Award of Excellence for their manuscript assessing rosiglitazone and pioglitazone utilization trends and associated medical and pharmacy claims data indicating risk for an adverse cardiovascular event.

January 27, 2009

Triessent® Becomes HCSC’s Specialty Pharmacy Provider
Prime Therapeutics (Prime) announced today that Health Care Service Corporation (HCSC) has selected Triessent® as its primary specialty pharmacy program. On January 1, 2009, Prime began providing a portion of HCSC's health benefits business with specialty pharmacy services.

December 17, 2008

Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Prime Therapeutics (Prime), a nationwide pharmacy benefit management (PBM) company, announced today that Steven Blumenfield has joined the organization as Chief Marketing Officer (CMO).

December 10, 2008

Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
Prime Therapeutics LLC (Prime) announces that it has been chosen by Blue Cross and Blue Shield of Montana (BCBSMT) to provide commercial pharmacy benefit management services, beginning January 1, 2009.

December 2, 2008

Prime Therapeutics to Provide Pharmacy Mail Service to Excellus BlueCross BlueShield Members
Prime Therapeutics (Prime) announced today it has entered into an agreement with Rochester, New York-based Excellus BlueCross BlueShield (BCBS) to provide pharmacy mail service to approximately 1.2 million health plan members through PrimeMail®, Prime’s mailservice pharmacy, beginning January 1, 2009.

October 20, 2008

BCBSTX is recognized to enhanced statin therapy efficiency program
Blue Cross and Blue Shield of Texas (BCBSTX), in collaboration with Prime Therapeutics (Prime), announced today that it has implemented an award-winning integrated medical and pharmacy claims program -- Enhancing Statin Therapy Efficiency.

September 23, 2008

Prime Therapeutics Receives 2009 TIPPS Certification
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today its 2009 Transparency in Pharmaceutical Purchasing Standards (TIPPS) certification.

August 27, 2008

Prime Therapeutics Connects Physicians to Mail Order Pharmacy through SureScripts-RxHub Network
Prime Therapeutics, a thought leader in pharmacy benefit management, announced today that it has completed certification with SureScripts-RxHub.

August 13, 2008

Prime Therapeutics Releases Annual Drug Trend Insights Report
Prime Therapeutics, a thought leader in pharmacy benefit management, today released its 2008 Drug Trend Insights report which revealed that its 2007 prescription drug trend increased by just 2.9 percent — the lowest annual increase it ever recorded, and less than half of what the company recorded in 2006.

July 28, 2008

Prime Therapeutics Supports CMS Proposal to Limit Spread Pricing in Medicare Part D Administration
Prime Therapeutics (Prime) today commented on CMS’s recently released proposal to require "spread pricing" by pharmacy benefits managers (PBMs) to be appropriately accounted for and reported as administrative costs.

June 26, 2008

Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
Prime Therapeutics (Prime) announced today the hiring of Jerry Steffl as Vice President, Government Affairs

May 22, 2008

Prime Therapeutics Receives VIPPS Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that it has received accreditation from the National Association of Boards of Pharmacy® (NABP®) through its Verified Internet Pharmacy Practice Sites™ (VIPPS®) Program.

May 12, 2008

Prime Therapeutics Providing Full-Service Pharmacy Benefit Management Services to Blue Cross and Blue Shield of Oklahoma
Prime Therapeutics (Prime) announced today that it has begun providing new services for its Blue Cross and Blue Shield of Oklahoma client. These new services mark the beginning of Blue Cross and Blue Shield of Oklahoma as a full-service client of Prime.

April 24, 2008

Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Rachelle Wan, RPh, has joined the organization as Vice President of Pharmacy Trade Relations.

April 21, 2008

Increased Out-of-Pocket Expenses May Negatively Influence Initiation of TNF Blocker Therapy
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, today announced the results of its study, "Association Between Tumor Necrosis Factor (TNF) Blocker Out-of-Pocket (OOP) Expense and Member Decline to Fill Rate".

March 25, 2008

Prime Therapeutics Introduces Triessent Specialty Pharmacy Program
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, recently announced the launch of its specialty pharmacy program, Triessent.

February 28, 2008

Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
Prime Therapeutics launches the Efficiency Program, a targeted approach to value-based pharmacy management, that helps employers understand how to spend their limited health care dollars in ways that are most beneficial to the health of their employees.

January 30, 2008

Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
Prime Therapeutics (Prime) has joined the Center for Health Value Innovation as the first participant from the pharmacy benefit management (PBM) industry.

December 6, 2007

Safety Concerns Prompt Prime to Remove Avandia^® from Formulary
Pharmacy benefit manager Prime Therapeutics (Prime) recently announced the removal of the prescription drug Avandia^® from its national formulary. After careful examination of clinical literature regarding the safety and efficacy of Avandia, Prime's National Pharmacy and Therapeutics (P&T) Committee has made the decision to remove the drug from its formulary. Prime's P&T Committee is a panel of pharmacists and physicians that meets quarterly and reviews drugs for Prime's formulary.

December 1, 2007

Prime Therapeutics Hires Charles Roehrick as Chief Financial Officer
Prime Therapeutics (Prime), a nationwide pharmacy benefit management company, recently announced that Charles Roehrick has joined the organization as Chief Financial Officer.

November 29, 2007

Prime Therapeutics Hires Will Lambert as Vice President of Provider Network Services
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Will Lambert has joined the organization as Vice President of Provider Network Services.

October 23, 2007

Prime Therapeutics Contracts with Blue Shield of California
Prime Therapeutics LLC (Prime) has entered into an agreement with Blue Shield of California (Blue Shield) to provide Blue Shield's mail pharmacy services, beginning January 1, 2008.

October 3, 2007

Prime Therapeutics Announces URAC Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today it has achieved URAC Pharmacy Benefit Management (PBM) accreditation.

September 6, 2007

Prime Therapeutics Receives TIPPS Certification
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today its 2008 Transparency in Pharmaceutical Purchasing Standards ^SM (TIPPS ^SM) certification.

July 16, 2007

Prime Therapeutics Hires Erin Ascher as Vice President of Human Resources
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Erin Ascher has joined the organization as Vice President of Human Resources.

July 9, 2007

Prime Therapeutics Releases 2006 Drug Trend Insights
For the fourth consecutive year, Prime Therapeutics (Prime) reported a single digit drug trend increase for 2006. According to the pharmacy benefit management company's 2006 Drug Trend Insights, released today, Prime had a 5.9 percent increase for overall drug spending in 2006.

June 28, 2007

Prime Hires Arthur Palileo as Vice President of Enterprise Program Management and Integration
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Arthur Palileo has joined the organization as Vice President of Enterprise Program Management and Integration.

June 12, 2007

Prime Therapeutics Announces Participation in URAC Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today their participation in URAC's efforts to create a pharmacy benefit management (PBM) accreditation program for the commercial markets.

April 26, 2007

Prime Therapeutics Promotes Kim Mageau to Chief Operating Officer
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today the promotion of Kim Mageau to Chief Operating Officer.

April 10, 2007

Study Shows Children with ADHD who Start on Strattera^® are More Likely to Change Therapies
Pharmacy benefit manager Prime Therapeutics (Prime) today announced the results of a study on the utilization of Strattera^® (atomoxetine) for treating attention deficit hyperactivity disorder (ADHD) in children.

January 16, 2007

Study finds 90 Percent of Actiq^® "Lollipop" Prescriptions are Off-label
A recent Prime Therapeutics (Prime) study found significant patterns of "off-label" prescribing for Actiq^® among patients taking the powerful painkilling "lollipop." Prescribing Actiq according to FDA guidelines is important for patient safety reasons because of the drug's serious side effects, including its addictive nature.